Earnings call transcript: hGears AG reports mixed Q2 2025 results

hGears AG reported mixed Q2 2025 results, with revenue declining 1.8% to €49.5 million and gross profit down, yet adjusted EBITDA more than doubled to €1.1 million, largely due to significant cost reductions and robust 19.4% growth in its E-Tools segment. Despite persistent E-bike sector challenges from inventory overhang and continued negative free cash flow of €2.3 million, the company reaffirmed its 2025 guidance, emphasizing operational efficiencies and cautious optimism for a 2026 market stabilization, though potential U.S. trade tariffs pose a risk. The stock reacted with a 2.21% decline, aligning with InvestingPro's 'weak' financial health assessment.

Analysis

hGears AG's Q2 2025 results reflect a company executing on internal cost controls while facing severe external market headwinds. Although adjusted EBITDA more than doubled to €1.1 million, this figure is misleading as it was primarily driven by significant cost reductions, including a €1 million cut in personnel costs, and a strategic pull-forward of approximately €3 million in production from the second half of the year. The top-line remains weak, with group sales declining 1.8% to €49.5 million, dragged down by a 28.6% contraction in the E-bike segment and a 3% dip in E-Mobility. The E-Tools segment was a notable exception, with 19.4% growth, but faces potential risk from U.S. tariffs. Critically, management has reiterated its full-year 2025 guidance, projecting revenues of €80-€90 million and an adjusted EBITDA loss between €1-€4 million, implying a significantly weaker second half. The company's financial health is a concern, underscored by a negative free cash flow of -€2.3 million and an InvestingPro health score of 1.45, indicating 'WEAK' fundamentals despite a low Price/Book ratio of 0.36.

Key Decisions for Investors

• Investors should heavily discount the positive H1 adjusted EBITDA, as management explicitly stated it was inflated by a €3 million pull-forward in production, and instead focus on the full-year guidance which projects a significant operational loss in the second half.
• Monitor leading indicators for the European E-bike inventory cycle and any developments regarding U.S. trade tariffs, as these external factors are critical to the timing of a potential 2026 recovery and the performance of the key E-Tools growth segment.
• Evaluate the stock's low Price/Book ratio against its persistent negative free cash flow and 'WEAK' financial health score to determine if it represents a deep value opportunity or a value trap pending clear signs of market stabilization.
• Closely track management's execution on cash preservation and cost controls through the challenging second half, as this will be the key determinant of the company's ability to weather the downturn and capitalize on an eventual market rebound.